Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 3,333 $ 3,791
Restricted deposit 12 12
Trade receivables 830 79
Other accounts receivable and prepaid expenses 239 270
Inventory 1,262 888
Total current assets 5,676 5,040
Restricted deposit 181 168
Operating lease right-of-use assets 2,796 3,215
Property and equipment, net 2,106 2,329
Intangible assets 82  
Total non-current assets 5,165 5,712
Total assets 10,841 10,752
Liabilities and shareholders’ equity    
Current maturity of loan   24
Trade payables 798 833
Operating lease liabilities 440 455
Deferred revenues 207 942
Accrued liabilities and other 1,943 1,203
Total current liabilities 3,388 3,457
Derivatives liability 28 68
Operating lease liabilities 2,948 3,139
Total non-current liabilities 2,976 3,207
Total liabilities 6,364 6,664
Commitments and contingencies
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2020 and December 31, 2019; issued and outstanding: 6,963,838 and 5,670,829 ordinary shares as of December 31, 2020 and December 31, 2019, respectively 2,933 2,368
Additional paid in capital and warrants 75,547 69,949
Currency translation differences (969) (969)
Accumulated deficit (73,034) (67,260)
Total shareholders’ equity 4,477 4,088
Total liabilities and shareholders’ equity $ 10,841 $ 10,752